1.27
-0.04(-3.05%)
Currency In USD
| Previous Close | 1.31 |
| Open | 1.3 |
| Day High | 1.3 |
| Day Low | 1.23 |
| 52-Week High | 5.4 |
| 52-Week Low | 1.05 |
| Volume | 56,869 |
| Average Volume | 182,490 |
| Market Cap | 43.66M |
| PE | -3.43 |
| EPS | -0.37 |
| Moving Average 50 Days | 1.29 |
| Moving Average 200 Days | 1.53 |
| Change | -0.04 |
If you invested $1000 in Telomir Pharmaceuticals, Inc. Common Stock (TELO) since IPO date, it would be worth $31,750 as of February 28, 2026 at a share price of $1.27. Whereas If you bought $1000 worth of Telomir Pharmaceuticals, Inc. Common Stock (TELO) shares 2 years ago, it would be worth $181.43 as of February 28, 2026 at a share price of $1.27.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Telo Genomics Corp. Announces Upsizing of Previously Announced Private Placement
Newsfile
3 hours ago
Vancouver, British Columbia--(Newsfile Corp. - February 27, 2026) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (the "Company" or "Telo Genomics"), a leader in the development of diagnostic and prognostic tests for human disease through the analy
Telo Genomics Closes First Tranche of Convertible Debentures Financing
Newsfile
Feb 18, 2026 12:00 PM GMT
THIS NEWS RELEASE IS NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATESVancouver, British Columbia--(Newsfile Corp. - February 18, 2026) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (the "Company" or "Telo G
Telo Genomics Announces Non-Brokered Private Placement of Convertible Debentures for up to $1,200,000
Newsfile
Jan 19, 2026 1:00 PM GMT
THIS NEWS RELEASE IS NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATESToronto, Ontario--(Newsfile Corp. - January 19, 2026) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (the "Company" or "Telo Genomics") is